Rick E. Winningham
Chief Executive Officer, Innoviva, Inc.
Companies
- Theravance Biopharma, Inc.Board member May 14, 2014 to now1
- Theravance Biopharma, Inc.Chief executive officer May 14, 2014 to now1
- Jazz PharmaceuticalsBoard member May 5, 2010 to now2
- OncoMedBoard member Jun 26, 2015 to Jun 25, 20183
- Innoviva, Inc.Board member Feb 10, 2006 to Aug 19, 20144
- Innoviva, Inc.Chief executive officer Feb 10, 2006 to Jun 18, 20144
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Jazz Pharmaceuticals JAZZ9,466 shares5$2.0M at $214.42Aug 31, 2026
- Theravance Biopharma, Inc. TBPH0 shares6Sep 23, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 23, 2026Returned to company 92,567 shares of Theravance Biopharma, Inc.6
- Sep 23, 2026Returned to company 23,400 shares of Theravance Biopharma, Inc.6
- Sep 23, 2026Returned to company 76,875 shares of Theravance Biopharma, Inc.6
- Sep 23, 2026Returned to company 151,875 shares of Theravance Biopharma, Inc.6
- Sep 23, 2026Returned to company 1,382,272 shares of Theravance Biopharma, Inc.6
- Aug 31, 2026Shares withheld for tax 14 shares at $244.64 of Jazz Pharmaceuticals5
- Aug 31, 2026Shares withheld for tax 1,692 shares at $241.39 of Jazz Pharmaceuticals5
- Aug 20, 2026Shares withheld for tax 20,034 shares at $16.95 of Theravance Biopharma, Inc.7
- Aug 5, 2026Granted 1,605 shares of Jazz Pharmaceuticals8
- May 22, 2026Sold 2,741 shares at $241.57 of Jazz Pharmaceuticals9
- May 22, 2026Exercised options 3,415 shares at $138.08 of Jazz Pharmaceuticals9
- May 20, 2026Shares withheld for tax 20,038 shares at $16.55 of Theravance Biopharma, Inc.10
- Apr 1, 2026Granted 75,000 shares of Theravance Biopharma, Inc.11
- Feb 20, 2026Shares withheld for tax 74,975 shares at $19.66 of Theravance Biopharma, Inc.12
- Nov 20, 2025Shares withheld for tax 56,817 shares at $17.90 of Theravance Biopharma, Inc.13
- Nov 19, 2025Gift 9,900 shares of Theravance Biopharma, Inc.13
- Nov 19, 2025Gift 9,900 shares of Theravance Biopharma, Inc.13
- Nov 18, 2025Sold 5,500 shares at $180.86 of Jazz Pharmaceuticals14
- Aug 20, 2025Shares withheld for tax 15,394 shares at $13.39 of Theravance Biopharma, Inc.15
- Aug 8, 2025Shares withheld for tax 1,805 shares at $111.25 of Jazz Pharmaceuticals16
- Aug 7, 2025Granted 3,507 shares of Jazz Pharmaceuticals16
- Jun 23, 2025Gift 20,000 shares of Theravance Biopharma, Inc.17
- Jun 13, 2025Gift 9,600 shares of Theravance Biopharma, Inc.18
- Jun 13, 2025Gift 9,600 shares of Theravance Biopharma, Inc.18
- May 20, 2025Shares withheld for tax 15,364 shares at $9.45 of Theravance Biopharma, Inc.19
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARJazz Pharmaceuticals, Board member
- 3SEC EDGAROncoMed, Board member
- 4SEC EDGARInnoviva, Inc., Board member
- 5
- 6
- 7SEC EDGARForm 4 filed Aug 24, 2026
- 8SEC EDGARForm 4 filed Aug 7, 2026
- 9SEC EDGARForm 4 filed May 27, 2026
- 10SEC EDGARForm 4 filed May 22, 2026
- 11SEC EDGARForm 4 filed Apr 3, 2026
- 12SEC EDGARForm 4 filed Feb 24, 2026
- 13SEC EDGARForm 4 filed Nov 21, 2025
- 14SEC EDGARForm 4 filed Nov 20, 2025
- 15SEC EDGARForm 4 filed Aug 22, 2025
- 16SEC EDGARForm 4 filed Aug 11, 2025
- 17SEC EDGARForm 4 filed Jun 25, 2025
- 18SEC EDGARForm 4 filed Jun 17, 2025
- 19SEC EDGARForm 4 filed May 22, 2025